233 related articles for article (PubMed ID: 26177317)
1. Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
Eloy C; Ferreira L; Salgado C; Soares P; Sobrinho-Simões M
Turk Patoloji Derg; 2015; 31 Suppl 1():48-59. PubMed ID: 26177317
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated and anaplastic thyroid cancer.
Patel KN; Shaha AR
Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.
Soares P; Lima J; Preto A; Castro P; Vinagre J; Celestino R; Couto JP; Prazeres H; Eloy C; Máximo V; Sobrinho-Simões M
Curr Genomics; 2011 Dec; 12(8):609-17. PubMed ID: 22654560
[TBL] [Abstract][Full Text] [Related]
4. Variants of Papillary Thyroid Carcinoma: Multiple Faces of a Familiar Tumor.
Sak SD
Turk Patoloji Derg; 2015; 31 Suppl 1():34-47. PubMed ID: 26177316
[TBL] [Abstract][Full Text] [Related]
5. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M
Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
[TBL] [Abstract][Full Text] [Related]
7. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
[TBL] [Abstract][Full Text] [Related]
8. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated thyroid cancer.
Patel KN; Shaha AR
Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):121-6. PubMed ID: 24492853
[TBL] [Abstract][Full Text] [Related]
10. Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.
Aratake Y; Nomura H; Kotani T; Marutsuka K; Kobayashi K; Kuma K; Miyauchi A; Okayama A; Tamura K
Am J Clin Pathol; 2006 Mar; 125(3):399-406. PubMed ID: 16613343
[TBL] [Abstract][Full Text] [Related]
11. The concepts in poorly differentiated carcinoma of the thyroid: a review article.
Nambiar A; Pv S; Susheelan V; Kuriakose MA
J Surg Oncol; 2011 Jun; 103(8):818-21. PubMed ID: 21283991
[TBL] [Abstract][Full Text] [Related]
12. Role of immunohistochemistry in the diagnosis and progression of follicular epithelium-derived thyroid carcinoma.
Rezk S; Khan A
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):256-64. PubMed ID: 16082252
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
[TBL] [Abstract][Full Text] [Related]
14. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.
Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD
Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811
[TBL] [Abstract][Full Text] [Related]
15. [Undifferentiated carcinomas of the thyroid corpus. Apropos of 10 cases].
Habib K; Auriol M; Sarfati E; de Roquancourt A; Wann AR; Brocheriou C; Chomette G
Arch Anat Cytol Pathol; 1993; 41(3-4):129-39. PubMed ID: 8279854
[TBL] [Abstract][Full Text] [Related]
16. Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.
Picarsic JL; Buryk MA; Ozolek J; Ranganathan S; Monaco SE; Simons JP; Witchel SF; Gurtunca N; Joyce J; Zhong S; Nikiforova MN; Nikiforov YE
Pediatr Dev Pathol; 2016; 19(2):115-22. PubMed ID: 26367451
[TBL] [Abstract][Full Text] [Related]
17. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
Schröder S
Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
[TBL] [Abstract][Full Text] [Related]
18. [Research progress in poorly differentiated thyroid carcinoma].
Chen H; Feng T; Li X; Wang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1083-7. PubMed ID: 25355270
[TBL] [Abstract][Full Text] [Related]
19. [Problem areas of tumour classifications--thyroid carcinomas].
Schmid KW
Verh Dtsch Ges Pathol; 2007; 91():57-65. PubMed ID: 18314596
[TBL] [Abstract][Full Text] [Related]
20. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
Baloch ZW; LiVolsi VA
Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
